Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study

No consensus exists on how to reduce oral corticosteroids after the initiation of biologics in severe asthma. The PONENTE trial evaluated the effectiveness and safety of a rapid, individualised steroid-reduction algorithm, including adrenal insufficiency monitoring, after benralizumab initiation. Th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The lancet respiratory medicine 2022-01, Vol.10 (1), p.47-58
Hauptverfasser:	Menzies-Gow, Andrew, Gurnell, Mark, Heaney, Liam G, Corren, Jonathan, Bel, Elisabeth H, Maspero, Jorge, Harrison, Timothy, Jackson, David J, Price, David, Lugogo, Njira, Kreindler, James, Burden, Annie, de Giorgio-Miller, Alex, Padilla, Kelly, Martin, Ubaldo J, Garcia Gil, Esther
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!